BriaCell Therapeutics Corp (NASDAQ: BCTX) started the day on Thursday, with a price decrease of -5.13% at $0.65, before settling in for the price of $0.69 at the close. Taking a more long-term approach, BCTX posted a 52-week range of $0.61-$29.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 47.85%. Meanwhile, its Annual Earning per share during the time was 47.85%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 67.56%. This publicly-traded company’s shares outstanding now amounts to $17.55 million, simultaneously with a float of $17.37 million. The organization now has a market capitalization sitting at $11.49 million. At the time of writing, stock’s 50-day Moving Average stood at $1.6857, while the 200-day Moving Average is $5.0564.
BriaCell Therapeutics Corp (BCTX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. BriaCell Therapeutics Corp’s current insider ownership accounts for 1.05%, in contrast to 16.25% institutional ownership.
BriaCell Therapeutics Corp (BCTX) Earnings and Revenue Records
BriaCell Therapeutics Corp’s EPS increase for this current 12-month fiscal period is 67.56% and is forecasted to reach -1.77 in the upcoming year.
BriaCell Therapeutics Corp (NASDAQ: BCTX) Trading Performance Indicators
Let’s observe the current performance indicators for BriaCell Therapeutics Corp (BCTX). It’s Quick Ratio in the last reported quarter now stands at 3.41.
In the same vein, BCTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -8.25, a figure that is expected to reach -1.39 in the next quarter, and analysts are predicting that it will be -1.77 at the market close of one year from today.
Technical Analysis of BriaCell Therapeutics Corp (BCTX)
If we take a close look at the recent performances of BriaCell Therapeutics Corp (NASDAQ: BCTX), its last 5-days Average volume was 0.52 million that shows plunge from its year to date volume of 1.12 million. During the previous 9 days, stock’s Stochastic %D was recorded 30.75% While, its Average True Range was 26.32%.
Raw Stochastic average of BriaCell Therapeutics Corp (BCTX) in the period of the previous 100 days is set at 0.49%, which indicates a major fall in contrast to 24.94% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0551 that was lower than 0.2931 volatility it exhibited in the past 100-days period.
